MARKET

TENX

TENX

Tenax Therapeutics Inc
NASDAQ
13.98
+0.14
+1.01%
After Hours: 14.77 +0.79 +5.65% 19:12 03/16 EDT
OPEN
14.42
PREV CLOSE
13.84
HIGH
14.96
LOW
13.81
VOLUME
387.42K
TURNOVER
--
52 WEEK HIGH
18.38
52 WEEK LOW
4.630
MARKET CAP
240.42M
P/E (TTM)
-10.4235
1D
5D
1M
3M
1Y
5Y
1D
Tenax Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones · 11h ago
Guggenheim Maintains Buy on Tenax Therapeutics, Raises Price Target to $34
Benzinga · 11h ago
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
TipRanks · 13h ago
Analysts Are Bullish on Top Healthcare Stocks: Savara (SVRA), Erasca (ERAS)
TipRanks · 13h ago
Weekly Report: what happened at TENX last week (0309-0313)?
Weekly Report · 14h ago
Tenax Therapeutics initiated with an Outperform at LifeSci Capital
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), RegenXBio (RGNX) and Foghorn Therapeutics (FHTX)
TipRanks · 4d ago
Roth MKM Keeps Their Buy Rating on Tenax Therapeutics (TENX)
TipRanks · 5d ago
More
About TENX
Tenax Therapeutics, Inc. is a Phase 3 development-stage pharmaceutical company. The Company is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The Company's products include TNX-201 (oral enteric-coated imatinib) and TNX-103 (oral levosimendan). The Company is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). The Company’s other programs include TNX-101 and TNX-102. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. The Company has completed the Phase II trial of levosimendan in patients with PH and heart failure with preserved ejection fraction (HFpEF).

Webull offers Tenax Therapeutics Inc stock information, including NASDAQ: TENX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TENX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TENX stock methods without spending real money on the virtual paper trading platform.